SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Vincerx Pharma, Inc. Merger

Wilmington, Delaware--(Newsfile Corp. - January 2, 2025) - Rigrodsky Law, P.A. is investigating Vincerx Pharma, Inc. ("Vincerx") (NASDAQ CM: VINC) regarding possible breaches of fiduciary duties and other violations of law related to Vincerx's agreement to merge with Oqory, Inc.

To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-vincerx-pharma-inc.

To contact Seth D. Rigrodsky or Gina M. Serra cost free, call (302) 295-5310 or email [email protected].

Rigrodsky Law, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide.

Attorney advertising. Prior results do not guarantee a similar outcome.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/235914

You May Also Be Interested In

• Scinai posts H1 2026 results with wider operating loss, net gain
• USA Rare Earth secures $1.55 billion SPV for Serra Verde offtake
• North Arrow Extends Target AE Strike Length to 1000 m and Completes Rotation 3 Regional RC Drilling, Kraaipan Gold Project, Botswana